Susan Tett
Susan Tett
School of Pharmacy, University of Queensland
Verified email at
Cited by
Cited by
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz, SE Tett
Clinical pharmacokinetics 43, 623-653, 2004
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients
CE Staatz, SE Tett
Clinical pharmacokinetics 46, 13-58, 2007
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis
JF Roos, J Doust, SE Tett, CMJ Kirkpatrick
Clinical biochemistry 40 (5-6), 383-391, 2007
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
CE Staatz, LK Goodman, SE Tett
Clinical pharmacokinetics 49, 141-175, 2010
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
DRJ Kuypers, Y Le Meur, M Cantarovich, MJ Tredger, SE Tett, D Cattaneo, ...
Clinical journal of the American Society of Nephrology 5 (2), 341-358, 2010
Bioavailability of hydroxychloroquine tablets in healthy volunteers.
SE Tett, DJ Cutler, RO Day, KF Brown
British journal of clinical pharmacology 27 (6), 771-779, 1989
Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update
CE Staatz, SE Tett
Archives of toxicology 88, 1351-1389, 2014
A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.
SE Tett, DJ Cutler, RO Day, KF Brown
British journal of clinical pharmacology 26 (3), 303-313, 1988
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
CE Staatz, C Willis, PJ Taylor, SE Tett
Clinical Pharmacology & Therapeutics 72 (6), 660-669, 2002
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
C Staatz, P Taylor, S Tett
Nephrology Dialysis Transplantation 16 (9), 1905-1909, 2001
Systematic review of interventions to improve prescribing
R Ostini, D Hegney, C Jackson, M Williamson, JM Mackson, K Gurman, ...
Annals of Pharmacotherapy 43 (3), 502-513, 2009
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
SE Tett, F Saint-Marcoux, CE Staatz, M Brunet, AA Vinks, M Miura, ...
Transplantation reviews 25 (2), 47-57, 2011
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration
ME DelDot, J Lipman, SE Tett
British journal of clinical pharmacology 58 (3), 259-268, 2004
Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia
BA Atcheson, PJ Taylor, CMJ Kirkpatrick, SB Duffull, DW Mudge, ...
Therapeutic drug monitoring 26 (3), 284-286, 2004
Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant
BA Atcheson, PJ Taylor, DW Mudge, DW Johnson, CM Hawley, ...
British journal of clinical pharmacology 59 (3), 271-280, 2005
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
SJ Carmichael, B Charles, SE Tett
Therapeutic drug monitoring 25 (6), 671-681, 2003
Clinical pharmacokinetics of slow-acting antirheumatic drugs
SE Tett
Clinical pharmacokinetics 25, 392-407, 1993
Principles and clinical application of assessing alterations in renal elimination pathways
SE Tett, CMJ Kirkpatrick, AS Gross, AJ McLachlan
Clinical pharmacokinetics 42, 1193-1211, 2003
Multiple medication use in the elderly: use of prescription and non‐prescription drugs in an Australian community setting
LA Simons, J Simons, I Powell, S Tett, R Lauchlan, J McCallum, ...
Medical journal of Australia 157 (4), 242-246, 1992
Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients
CE Staatz, SE Tett
Clinical pharmacokinetics 54, 993-1025, 2015
The system can't perform the operation now. Try again later.
Articles 1–20